Citations

Clear

196 citation(s) found for "Schultz, M".

System of Psychological Support Based on Positive Suggestions to the Critically Ill Using ICU Doulas
Karnatovskaia, Lioudmila V. , Schultz, Jason, Steele, Amanda J., Baker, Brittany A., Philbrick, Kemuel L. , Valle, Kathryn T. del , Johnson, Kimberly R. , Gajić, Ognjen, Varga, Katalin , Schultz, Jason M, Del Valle, Kathryn T, Del Valle, Kathryn T , Niven, Alexander S. , Baker, Brittany A., Gajic, Ognjen

Mayo Clinic

Critical Care Explorations | April 27, 2021 | Volume: 3 | Issue: 4 | Pages: e0403

10.1097/cce.0000000000000403 | PMID 33912833 Get It

Background: Surviving critical illness often creates a lasting psychological impact, including depression, anxiety, and post-traumatic stress. Memories of frightening and delusional experiences are the largest potentially modifiable risk factor, but currently, there is no proven intervention to improve these inciting factors. Psychological support based on positive suggestion is a psychotherapeutic approach that can be provided even to patients in altered cognitive states and is therefore a viable psychotherapy intervention throughout the ICU stay. Traditional ICU care team members have limited time and training to provide such psychological support to patients. Doulas are trained supportive companions who have been effectively used to provide patient advocacy and emotional support in other clinical settings and may address this need. Our aim was to train and implement a psychological support based on positive suggestion program for the critically ill using doulas, and measure acceptance of this intervention through stakeholder feedback. Methods: Doula training included three objectives: an introduction to ICU practice structure and policies; education about fundamental aspects of critical care conditions and procedures; and didactic and hands-on learning experiences in effective use of psychological support based on positive suggestion in the critically ill. Doulas were evaluated at the end of their training and during subsequent clinical activities using competency-based assessments as well as through survey-based questions and interviews with key stakeholders. Results: The ICU doulas performed psychological support based on positive suggestion on 43 critically ill patients in the ICU setting. Stakeholder feedback from nurses, patients, and patient families was positive. The majority (28/32) of surveyed bedside ICU nurses reported that the doulas’ involvement was helpful for both patients and nurses alike. All interviewed family members offered positive comments about the ICU doula presence and of the 40 patients who recalled the intervention 37 found it comforting. Conclusions: Our program successfully trained two doulas to work effectively in the ICU setting performing patient-centered psychological support based on positive suggestion interventions. Their training improved their skill sets and was reported as beneficial by patients, families, and critical care nursing. This training program offers a proof of concept that could be applied in other medical centers, bringing doulas more commonly into the ICU practice to help humanize the experience for patients, families, and medical teams.
Comparison of 1 vs 2 Brain Death Examinations on Time to Death Pronouncement and Organ Donation
Varelas, Panayiotis N. , Rehman, Mohammed, Mehta, Chandan, Louchart, Lisa, Schultz, Lonni, Brady, Paul, Kananeh, Mohammed , Wijdicks, Eelco F. M. , Kananeh, Mohammed F, Wijdicks, Eelco Fm , Brady, Paul

Mayo Clinic

Neurology | March 8, 2021 | Volume: 96 | Issue: 10 | Pages: No page available

10.1212/wnl.0000000000011554 | PMID 33514644 Get It

Checklist for Early Recognition and Treatment of Acute Illness and Injury: An Exploratory Multicenter International Quality-Improvement Study in the ICUs With Variable Resources
Adhikari, Neill K. J. , Schultz, Marcus J. , Martín‐Loeches, Ignacio , Hache, Manuel, Gavrilović, Srdjan , Martin-Loeches, Ignacio, Schultz, Marcus J , Martin-Loeches, Ignacio , Vukoja, Marija , Dong, Yue , Arabi, Yaseen M. , Kashyap, Rahul , Gajic, Ognjen

Mayo Clinic

Critical Care Medicine | February 27, 2021 | Volume: 49 | Issue: 6 | Pages: e598-e612

10.1097/ccm.0000000000004937 | PMID 33729718 Get It

OBJECTIVES: To determine whether the “Checklist for Early Recognition and Treatment of Acute Illness and Injury” decision support tool during ICU admission and rounding is associated with improvements in nonadherence to evidence-based daily care processes and outcomes in variably resourced ICUs. DESIGN, SETTINGS, PATIENTS: This before-after study was performed in 34 ICUs (15 countries) from 2013 to 2017. Data were collected for 3 months before and 6 months after Checklist for Early Recognition and Treatment of Acute Illness and Injury implementation. INTERVENTIONS: Checklist for Early Recognition and Treatment of Acute Illness and Injury implementation using remote simulation training. MEASUREMENTS AND MAIN RESULTS: The coprimary outcomes, modified from the original protocol before data analysis, were nonadherence to 10 basic care processes and ICU and hospital length of stay. There were 1,447 patients in the preimplementation phase and 2,809 patients in the postimplementation phase. After adjusting for center effect, Checklist for Early Recognition and Treatment of Acute Illness and Injury implementation was associated with reduced nonadherence to care processes (adjusted incidence rate ratio [95% CI]): deep vein thrombosis prophylaxis (0.74 [0.68–0.81), peptic ulcer prophylaxis (0.46 [0.38–0.57]), spontaneous breathing trial (0.81 [0.76–0.86]), family conferences (0.86 [0.81–0.92]), and daily assessment for the need of central venous catheters (0.85 [0.81–0.90]), urinary catheters (0.84 [0.80–0.88]), antimicrobials (0.66 [0.62–0.71]), and sedation (0.62 [0.57–0.67]). Analyses adjusted for baseline characteristics showed associations of Checklist for Early Recognition and Treatment of Acute Illness and Injury implementation with decreased ICU length of stay (adjusted ratio of geometric means [95% CI]) 0.86 [0.80–0.92]), hospital length of stay (0.92 [0.85–0.97]), and hospital mortality (adjusted odds ratio [95% CI], 0.81 (0.69–0.95). CONCLUSIONS: A quality-improvement intervention with remote simulation training to implement a decision support tool was associated with decreased nonadherence to daily care processes, shorter length of stay, and decreased mortality.
Theoretical frameworks and approaches used within the Reserve, Resilience and Protective Factors professional interest area of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment
Ewers, Michael , Belleville, Sylvie , Chételat, Gaël , Gonneaud, Julie , Echevarri, José María González, Okonkwo, Ozioma C. , Schultz, Stephanie A. , Vemuri, Prashanthi , Seshadri, Sudha , Vemuri, Prashanthi , Seshadri, Sudha , Bartrés‐Faz, David , Arenaza‐Urquijo, Eider M. , Franzmeier, Nicolai , Valenzuela, Michael , Stern, Yaakov

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | November 11, 2020 | Volume: 12 | Issue: 1 | Pages: No page available

10.1002/dad2.12115 | PMID 33204812 Get It

Spectrum of Hematological Malignancies in 130 Patients with Germline Predisposition Syndromes - Mayo Clinic Germline Predisposition Study
DiFilippo, Emma C., Schultz‐Rogers, Laura , Gangat, Naseema , Khan, Shakila P. , Al‐Kali, Aref , Mangaonkar, Abhishek A. , Pardanani, Animesh , Elliot, Michelle, Litzow, Mark R. , Wolanskyj, Alexandra P., Nguyen, Phuong L., Reichard, Kaaren K. , Howard, Matthew T., King, Rebecca L. , He, Rong , Viswanatha, David S., Pruthi, Rajiv K. , Pichurin, Pavel N. , Kruisselbrink, Teresa , Lanpher, Brendan C. , Wylam, Mark E. , Oliveira, Jennifer L. , Babovic‐Vuksanovic, Dusica , Olteanu, Horatiu , Patnaik, Mrinal M. , Ferrer, Alejandro , Hogan, William J. , Chen, Dong , Lasho, Terra L.

Mayo Clinic

Blood | November 4, 2020 | Volume: 136 | Issue: Supplement 1 | Pages: 34-35

10.1182/blood-2020-139050 Get It

Introduction Germline predisposition syndromes (GPS) are inherited disorders associated with germinal aberrations that increase the risk of malignancies. While aberrations in certain genes increase the risk for all types of malignancies (Tp53, ATM, CDKN2A, CHEK2), there is a growing list of genes associated specifically with hematological malignancies (GATA2, RUNX1, DDX41, ETV6, ANKRD26). At our institution, we have established a hematology GPS clinic to diagnose and manage GPS and with this report, detail our experience with 130 patients. Methods GPS were investigated in pediatric and adult patients with one or more first degree relatives with hematological/visceral malignancies or in those with antecedent thrombocytopenia (ANKRD26, RUNX1, ETV6), or with specific syndromic features (short telomere syndromes/STS, GATA2 haploinsufficiency, Fanconi anemia/FA, Shwachman-Diamond syndrome/SDS). Depending on the phenotype, specific functional assays such as flow-FISH for telomere length assessment and chromosomal breakage assays were ordered. After informed consent and genetic counselling, germline testing was carried out on peripheral blood mononuclear cell, skin fibroblast, or hair follicle-derived DNA. A custom-designed marrow failure NGS panel (200 genes) was used in most cases and interrogation of variants, in silico studies, and functional assays were carried out as previously described (Mangaonkar et al MC Proc 2019). Copy number variations were identified by aCGH. At the time of progression/worsening cytopenias, bone marrow/lymph node biopsies and NGS (next generation sequencing) were carried out where indicated. Results 130 patients with germline predisposition have been identified to date. The spectrum of disorders seen include STS 29 (22%), FA 17 (13%), GATA2 16 (12%), Diamond Blackfan anemia/DBA 13 (10%), RUNX1-FPD 12 (9%), ATM deletions/mutations 11 (8%), ANKRD26 6 (5%), SDS 5 (4%), DDX41 4 (3%), MPL 3 (2%), CHEK2, MECOM, Tp53 mutations 2 (2%) each, and CBL, CEPBA, ELANE, NF1, CDKN2A, CSF3R, ETV6, and GATA1 mutations, 1 (1%) each. Evidence for clonal evolution (CCUS) and hematological malignancies were seen in 51 (39%) patients, involving all the aforementioned genes/syndromes with the exception of DBA, CBL, ETV6, MPL, CSF3R, and GATA1. Seven (64%) of 11 patients with germline ATM deletions/mutations developed lymphoid malignancies; homozygous ATM (Follicular NHL-1, Burkitt lymphoma-1, T-ALL-1, T-LPD-1) and heterozygous ATM (T-PLL-1, DLBCL-1, CLL-1). Clonal evolution occurred in 11 (69%) of 16 GATA2 haploinsufficient patients (CCUS-2, MDS-3, CMML-1, AML-5) and in 7 (58%) of 12 RUNX1-FPD patients (CCUS-1, MDS-1, MDS/MPN-3, AML-2). Five of 29 (17%) STS patients had clonal progression (CCUS-2, MDS-2, AML-1), and 5 (29%) of 17 FA patients progressed to MDS-2 or AML-3. JMML was seen in one patient with a germline NF1 mutation, while 1 (20%) of 5 SDS patients progressed to AML. NGS data at progression was available in 24 (55%) of 44 myeloid/CCUS progressions, with somatic truncating ASXL1 mutations being most frequent (29%), followed by RAS pathway mutations (15%). AML/MDS progressions in STS, FA, and SDS were universally associated with complex/monosomal karyotypes, translating to refractory disease. Seventeen (39%) of 44 patients with myeloid predisposition underwent allogenic HCT (GATA2-7, FA-3, RUNX1-FPD-3, STS-2, NF1-1, Tp53-1), with 10 (59%) being alive at last follow up (Table 1). Conclusion We demonstrate the spectrum of germline aberrations associated with predisposition to hematological malignancies and outline the phenotypic heterogeneity of clonal transformation. The advent of NGS allows identification of clonal progression earlier than morphological changes, with mutations in ASXL1 and RAS pathway genes being commonly implicated. This study supports the universal development of dedicated germline predisposition clinics. Disclosures Pruthi: CSL Behring: Honoraria; Genentech Inc.: Honoraria; Bayer Healthcare: Honoraria; HEMA Biologics: Honoraria; Instrumentation Laboratory: Honoraria; Merck: Honoraria.
S0819 Evaluating Cost Per Remission and Cost of Serious Adverse Events in Advanced Therapies for Ulcerative Colitis
Cohen, Russell D. , Candela, Ninfa , Lasch, Karen, Jairath, Vipul , Loftus, Edward V. , Schultz, Bob G.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2020 | Volume: 115 | Issue: 1 | Pages: S420-S421

10.14309/01.ajg.0000705324.95048.a6 Get It

Immune dysfunction in MGAT2‐CDG: A clinical report and review of the literature
Poskanzer, Sheri A. , Turgeon, Coleman , Vidal‐Folch, Noemi, Liedtke, Kris L., Oglesbee, Devin , Gavrilov, Dimitar K. , Tortorelli, Silvia , Matern, Dietrich , Rinaldo, Piero, Thies, Jenny , Chang, Irene J. , Beck, Anita E. , Raymond, Kimiyo , Lam, Christina , Turgeon, Coleman T, Vidal-Folch, Noemi, Liedtke, Kris, Bennett, James T , Thies, Jenny M , Chang, Irene J , Beck, Anita E , Raymond, Kimiyo , Allenspach, Eric J , Lam, Christina , Oglesbee, Devin , Poskanzer, Sheri A , Schultz, Matthew , Liedtke, Kristen

Mayo Clinic

American Journal of Medical Genetics Part A | October 12, 2020 | Volume: 185 | Issue: 1 | Pages: 213-218

10.1002/ajmg.a.61914 | PMID 33044030 Get It

AbstractGlycosylation is a critical post/peri‐translational modification required for the appropriate development and function of the immune system. As an example, abnormalities in glycosylation can cause antibody deficiency and reduced lymphocyte signaling, although the phenotype can be complex given the diverse roles of glycosylation. Human MGAT2 encodes N‐acetylglucosaminyltransferase II, which is a critical enzyme in the processing of oligomannose to complex N‐glycans. Complex N‐glycans are essential for immune system functionality, but only one individual with MGAT2‐CDG has been described to have an abnormal immunologic evaluation. MGAT2‐CDG (CDG‐IIa) is a congenital disorder of glycosylation (CDG) associated with profound global developmental disability, hypotonia, early onset epilepsy, and other multisystem manifestations. Here, we report a 4‐year old female with MGAT2‐CDG due to a novel homozygous pathogenic variant in MGAT2, a 4‐base pair deletion, c.1006_1009delGACA. In addition to clinical features previously described in MGAT2‐CDG, she experienced episodic asystole, persistent hypogammaglobulinemia, and defective ex vivo mitogen and antigen proliferative responses, but intact specific vaccine antibody titers. Her infection history has been mild despite the testing abnormalities. We compare this patient to the 15 previously reported patients in the literature, thus expanding both the genotypic and phenotypic spectrum for MGAT2‐CDG.
Haploinsufficiency as a disease mechanism in GNB1 ‐associated neurodevelopmental disorder
Schultz‐Rogers, Laura , Masuho, Ikuo , Schmitz, Christopher T., Schwab, Tanya L., Gunderson, Lauren, Pichurin, Pavel N. , Wierenga, Klaas J. , Martemyanov, Kirill A. , Klee, Eric W. , Pinto E Vairo, Filippo, Wierenga, Klaas, Klee, Eric W , Schmitz, Christopher , Vairo, Filippo Pinto e , Clark, Karl J.

Mayo Clinic

Molecular Genetics & Genomic Medicine | September 14, 2020 | Volume: 8 | Issue: 11 | Pages: No page available

10.1002/mgg3.1477 | PMID 32918542 Get It

Abstract Background GNB1 encodes a subunit of a heterotrimeric G‐protein complex that transduces intracellular signaling cascades. Disruptions to the gene have previously been shown to be embryonic lethal in knockout mice and to cause complex neurodevelopmental disorders in humans. To date, the majority of variants associated with disease in humans have been missense variants in exons 5‐7. Methods Genetic sequencing was performed on two patients presenting with complex neurological phenotypes including intellectual disability, hypotonia, and in one patient seizures. Reported variants were assessed using RNA sequencing and functional BRET/BiFC assays. Results A splice variant reported in patient 1 was confirmed to cause usage of a cryptic splice site leading to a truncated protein product. Patient 2 was reported to have a truncating variant. BRET and BiFC assays of both patient variants confirmed both were deficient in inducing GPCR‐induced G protein activation due to lack of dimer formation with the Gγ subunit. Conclusion Here, we report two patients with functionally confirmed loss of function variants in GNB1 and neurodevelopmental phenotypes including intellectual disability, hypotonia, and seizures in one patient. These results suggest haploinsufficiency of GNB1 is a mechanism for neurodevelopmental disorders in humans.